Sequenom Licenses Prenatal Genetic Screening IP From Isis | GenomeWeb
NEW YORK (GenomeWeb News) — Sequenom today said it has licensed Isis Innovation’s intellectual property for non-invasive prenatal genetic testing.
Under the agreement, Sequenom licensed rights for Isis’s non-invasive prenatal diagnostic testing on nucleic acids derived from maternal plasma or serum, the company said.
Isis is Oxford University’s technology transfer company. It works to develop and market commercial applications for intellectual property owned by the school.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.